eradmin – Page 1568 – Eritrea Wire

August 3, 2021

Dext launches new product to make managing sales data simpler: Dext Commerce

Solution helps accountants & bookkeepers take on digital sales clients profitably
Simplifies sales data and tax calculations for businesses selling via Shopify, Amazon, and other leading e-Commerce platforms

LONDON, Aug. 03, 2021 (GLOBE NEWSWIRE) — Accounting software provider Dext has added a digital sales product to its growing platform, following the acquisition of Greenback which rebrands to ‘Dext Commerce’.

Dext Commerce allows accountants and bookkeepers to take on more digital sales clients by simplifying the collection and categorisation of sales data from 16 e-commerce, POS and payment platforms including Amazon, PayPal, Shopify and Stripe. It also integrates with Xero and Quickbooks Online, enabling accountants and bookkeepers to accurately submit eCommerce revenue into the largest accounting platforms.

The solution solves the challenge of manually fetching and consolidating sales data from multiple commerce and payment platforms in different formats. Dext Commerce simplifies sales data and tax calculations across multiple countries, allowing accountants and bookkeepers to more profitably service digital sales clients.

Key Dext Commerce features include:

A digital record of sales transactions line by line to support compliance with new data regulations like ‘Making Tax Digital’ in the UK;
Making sure clients report and pay the right sales tax, wherever they sell;
Itemise sales, fees, refunds and reimbursements data, line by line, with one subscription;

E-commerce sales in the UK and US comprised c. 35% of total retail sales in 2021, nearly doubling in the UK¹.

Dext CEO, Adrian Blair, commented: “Millions of businesses now sell via eCommerce platforms like Amazon and Shopify. Dext Commerce enables accountants and bookkeepers to take on these businesses as clients more profitably. Dext Commerce solves two key pain points: getting standardised data, line by line, from multiple sources; and ensuring digital sellers accurately calculate how much tax to pay in different markets.”

Dext Commerce is available to all accountants, bookkeepers and businesses in the UK, US and Canada from September 1st, with rollout in France and Australia later this year.

¹ ONS, US Census: https://www.ben-evans.com/presentations

Paul-Reza Afshar
paul.afshar@dext.com

August 3, 2021

Lantronix Completes Acquisition of Electronics and Software Reportable Business Segment from Communications Systems, Inc.

IRVINE, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Lantronix, Inc. (“Lantronix”) (NASDAQ: LTRX), a global provider of Software as a Service (Saas), connectivity services, engineering services, intelligent hardware and turnkey solutions for the Internet of Things (IoT) and Remote Environment Management (REM), today announced that it has completed its previously announced acquisition of Transition Networks and Net2Edge, which comprises the majority of the Electronics and Software reportable business segment of Communications Systems, Inc. (NASDAQ: JCS) (“CSI”).

The transaction will bring immediate scale to Lantronix, with revenues from the combined company expected to total more than $100 million on an annual basis. The acquisition will bring complementary IoT connectivity products and capabilities, including switching, Power over Ethernet (PoE) and media conversion and adapter products.

Lantronix sees significant operating and product development synergies in the combined company and expects significant day one synergies will drive immediate non-GAAP earnings accretion upon closing, and the company further expects to realize $7 million in annual run rate synergies over the course of the first 24 months. Lantronix will release guidance for its fiscal year 2022 on its fourth quarter fiscal year 2021 earnings conference call, with that date to be named shortly.

Silicon Valley Bank, the bank of the world’s most innovative companies and their investors, along with SVB Capital, provided acquisition financing.

O’Melveny & Myers LLP served as legal advisor to Lantronix.

About Lantronix
Lantronix Inc. is a global provider of secure turnkey solutions for the Internet of Things (IoT) and Remote Environment Management (REM), offering Software as a Service (SaaS), connectivity services, engineering services and intelligent hardware. Lantronix enables its customers to provide reliable and secure IoT Intelligent Edge and OOBM solutions while accelerating time to market. Lantronix’s products and services dramatically simplify the creation, development, deployment and management of IoT projects while providing quality, reliability and security across hardware, software and solutions.

With three decades of proven experience in creating robust IoT technologies and OOBM solutions, Lantronix is an innovator in enabling its customers to build new business models, leverage greater efficiencies and realize the possibilities of the Internet of Things. Lantronix’s solutions are deployed inside millions of machines at data centers, offices and remote sites serving a wide range of industries, including energy, agriculture, medical, security, manufacturing, distribution, transportation, retail, financial, environmental and government.

Lantronix is headquartered in Irvine, Calif. For more information, visit www.lantronix.com.

Learn more at the Lantronix blog, www.lantronix.com/blog, featuring industry discussion and updates. To follow Lantronix on Twitter, please visit www.twitter.com/Lantronix. View our video library on YouTube at www.youtube.com/user/LantronixInc or connect with us on LinkedIn at www.linkedin.com/company/lantronix.

Discussion of Non-GAAP Financial Measures

Lantronix believes that the presentation of non-GAAP financial information, when presented in conjunction with the corresponding GAAP measures, provides important supplemental information to management and investors regarding financial and business trends relating to the company’s financial condition and results of operations. Management uses the aforementioned non-GAAP measures to monitor and evaluate ongoing operating results and trends to gain an understanding of our comparative operating performance. The non-GAAP financial measures disclosed by the company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations of the non-GAAP financial measures to the financial measures calculated in accordance with GAAP should be carefully evaluated. The non-GAAP financial measures used by the company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

Guidance on earnings per share growth is provided only on a non-GAAP basis due to the inherent difficulty of forecasting the timing or amount of certain items that have been excluded from the forward-looking non-GAAP measures, and a reconciliation to the comparable GAAP guidance has not been provided because certain factors that are materially significant to Lantronix’s ability to estimate the excluded items are not accessible or estimable on a forward-looking basis without unreasonable effort.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not strictly historical statements constitute forward-looking statements and may often, but not always, be identified by the use of such words such as “expects,” “believes,” “intends,” “anticipates,” “plans,” “estimates,” “potential,” “possible,” or “probable” or statements that certain actions, events or results “may,” “will,” “should,” or “could” be taken, occur or be achieved. The forward-looking statements in this press release include, among others, statements about the expected benefits of the acquisition of Transition Networks and Net2Edge (the “Transaction”), including expected synergies in the combined company, to Lantronix and its stockholders, the accretive nature of the proposed Transaction and expected future operating results of the combined company. Forward-looking statements are based on current expectations and assumptions and analyses made by Lantronix and its management in light of experience and perception of historical trends, current conditions, and expected future developments, as well as other factors appropriate under the circumstances. However, whether actual results and developments will conform to expectations is subject to a number of material risks and uncertainties, including but not limited to: Lantronix’s ability to integrate the acquired businesses successfully after the Transaction and achieve anticipated benefits from it; risks relating to any unforeseen liabilities of the acquired businesses; inaccuracies of reserve estimates or assumptions underlying them; revisions to reserve estimates as a result of changes in commodity prices; any loss of management or key personnel; the impact of the COVID-19 pandemic, including the emergence of new more contagious and/or vaccine-resistant strains of the virus and the impact of vaccination efforts, including the efficacy and public acceptance of vaccinations, on the combined companies’ business, employees, supply and distribution chains and the global economy; and any additional factors included in Lantronix’s Report on Form 10-K for the fiscal year ended June 30, 2020, filed with the Securities and Exchange Commission (the “SEC”) on September 11, 2020, including in the section entitled “Risk Factors” in Item 1A of Part I of such report; its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021, filed with the SEC on April 30, 2021, including in the section entitled “Risk Factors” in Item 1A of Part II of such report; and in the Company’s other public filings with the SEC. In addition, actual results may differ as a result of additional risks and uncertainties of which Lantronix management is currently unaware or does not currently view as material to the Company’s business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements Lantronix makes speak only as of the date on which they are made. Lantronix undertakes no obligation to revise or update publicly any forward-looking statements except as required by law or the rules of the Nasdaq Stock Market, LLC.

Lantronix Media Contact:
Gail Kathryn Miller
Corporate Marketing &
Communications Manager
media@lantronix.com
949-453-7158

Lantronix Analyst and Investor Contact:
Jeremy Whitaker
Chief Financial Officer
investors@lantronix.com
949-450-7241

Lantronix Sales:
sales@lantronix.com
Americas +1 (800) 422-7055 (US and Canada) or +1 949-453-3990
Europe, Middle East and Africa +31 (0)76 52 36 744
Asia Pacific + 852 3428-2338
China + 86 21-6237-8868
Japan +81 (0) 50-1354-6201
India +91 994-551-2488

August 3, 2021

Zoom Video Communications to Release Financial Results for the Second Quarter of Fiscal Year 2022

SAN JOSE, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM), a leading provider of frictionless enterprise communications, today announced it will release its financial results for the second quarter of fiscal year 2022 on Monday, August 30, 2021, after the market closes.

A live Zoom Video Webinar of the event can be accessed at 2:00 pm PT / 5:00 pm ET through Zoom’s investor relations website at https://investors.zoom.us. A replay will be available approximately two hours after the conclusion of the live event.

About Zoom
Zoom is for you. We help you express ideas, connect to others, and build toward a future limited only by your imagination. Our frictionless communications platform is the only one that started with video as its foundation, and we have set the standard for innovation ever since. That is why we are an intuitive, scalable, and secure choice for large enterprises, small businesses, and individuals alike. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Visit zoom.com and follow @zoom.

Public Relations
Colleen Rodriguez
Global PR Lead for Zoom
press@zoom.us

Investor Relations
Tom McCallum
Head of Investor Relations for Zoom
408.675.6738
investors@zoom.us

August 2, 2021

Vision Impact Institute Applauds UN Resolution on Vision

Resolution highlights impact of good vision to achieving the Sustainable Development Goals

DALLAS, Aug. 2, 2021 /PRNewswire/ — The Vision Impact Institute applauds the UN General Assembly’s adoption of the Vision for Everyone: accelerating action to achieve the Sustainable Development Goals resolution. A major step forward for vision correction, this resolution commits the international community to improving vision for 1.1 billion people living with preventable vision loss by 2030.

This topic is timely as societies cope with the fallout of the COVID-19 pandemic in terms of:

Children’s Education – The connection between vision and learning is crucial, as eighty percent of learning is visual. Yet, with increased digital learning, children are experiencing vision changes such as myopia and eye strain from more screen time and less time outdoors.

Road Safety – With up to 90% of the information needed for safety on the road coming through the eyes, good vision is a critical factor for safer mobility. This becomes more important as workers return to office buildings and businesses.

Gender Equity – Research suggests that 55% of people with vision loss are women and girls. Women can also face stigmas when it comes to wearing glasses. This burden, compounded with the burden that the COVID-19 pandemic has disproportionately placed on women, highlights the need for their good vision care.

“This resolution is a much-needed step to ensure that good vision is accessible to all,” says Kristan Gross, Global Executive Director, Vision Impact Institute. “As vision advocates, we have worked for years in partnership with others to ensure that vision is pivotal in the global development conversation. This unanimous decision is a testimony to the power of partnerships and coalitions that believe good vision is key to unlocking human potential.”

###

About the Vision Impact Institute (VII)
The VII’s mission is to raise awareness of the importance of vision correction and protection to make good vision a global priority. Its Advisory Board is comprised of four independent international experts: Pr. Clare Gilbert (United Kingdom), Mr. Allyala Nandakumar (United States), Dr. Serge Resnikoff (Switzerland), and Dr. Wang Wei (China).

The Vision Impact Institute is a registered 501(c)(3) non-profit organization, which receives support from the Vision for Life Fund from Essilor, the world leader in ophthalmic optics. The Vision Impact Institute hosts a unique database of research at visionimpactinstitute.org .

Contact:
Andrea Kirsten-Coleman
Global Communications Manager
andrea.kirsten@visionimpactinstitute.org

Logo – https://mma.prnewswire.com/media/832635/Vision_Impact_Institute_Logo.jpg

July 31, 2021

UL collabore avec WIZZIT Digital pour faire progresser les paiements de détail en Afrique subsaharienne avec le lancement d’une solution de paiement mobile SoftPOS avec PIN

UL et WIZZIT Digital contribuent à accélérer le déploiement des paiements sans contact pour favoriser l’inclusion financière et permettre aux commerçants de toutes tailles de réaliser leurs ambitions.

JOHANNESBURG, le 31 juillet 2021 /PRNewswire/ — UL, le leader mondial des sciences de la sécurité, a annoncé que WIZZIT Digital, une société de paiements numériques, a lancé une solution logicielle de point de vente (SoftPOS) Tap2Pay avec prise en charge de la saisie du numéro d’identification personnel (PIN). Cette solution permet de transformer des appareils commerciaux (COTS) en terminaux de paiement de point de vente (POS). Tap2Pay est la première solution SoftPOS développée en Afrique du Sud qui prend en charge la saisie du code PIN et est reconnue par Visa et Mastercard. WIZZIT Digital est désormais opérationnel avec un premier client de lancement, l’une des plus grandes banques commerciales panafricaines.

UL has announced that WIZZIT Digital has launched a Tap2Pay software point-of-sale (SoftPOS) solution with personal identification number (PIN) entry support. This solution transforms commercial off-the-shelf (COTS) devices into point-of-sale (POS) payment terminals. Tap2Pay is the first SoftPOS solution developed in South Africa that supports PIN entry and is recognized by Visa and Mastercard. (PRNewsfoto/UL)

Pour surmonter les difficultés liées à la mise sur le marché d’une solution SoftPOS, UL a soutenu la solution Tap2Pay depuis son développement jusqu’à son entrée sur le marché. Dans un premier temps, UL a fourni des services de conseil pour aider WIZZIT Digital à s’orienter dans le paysage réglementaire des paiements et à répondre aux exigences des systèmes de paiement. Lorsque Tap2Pay a été prêt pour les tests fonctionnels, UL l’a testé avec une série d’outils accrédités par le système afin de fournir un retour sur les problèmes potentiels. Après le débogage et le dépannage, UL a fourni des services de tests fonctionnels et a aidé WIZZIT Digital à obtenir l’approbation du type pilote Visa. Après l’approbation fonctionnelle, les laboratoires de sécurité d’UL ont évalué la solution pour les programmes pilotes de sécurité de Mastercard et de Visa. Ces tests et évaluations par rapport aux exigences du projet ont permis à WIZZIT de mettre la solution sur le marché.

L’évaluation d’UL a confirmé que la solution Tap2Pay répondait aux principales exigences de sécurité avant d’entrer sur le marché. Il s’agissait notamment d’aider à affirmer la sécurité des données de paiement obtenues par une interface de communication en champ proche (NFC) et un noyau sans contact du dispositif COTS. Les mécanismes de sécurité, les contrôles et les mesures d’atténuation de la solution protègent les données du compte du consommateur et d’autres actifs.

Tap2Pay entre sur le marché à un moment où la demande de solutions de paiement sans contact augmente. Selon Deloitte, la pandémie de COVID-19 a rendu le besoin de numérisation des paiements plus critique que jamais. Cependant, de nombreux marchés émergents sont confrontés à des problèmes d’acceptation des cartes. Deloitte a également noté qu’en Afrique du Sud, environ 90 % des 100 000 magasins du secteur informel n’acceptent que des espèces. Pour répondre à la demande des clients et accroître l’acceptation des cartes par le marché des petites entreprises, y compris les commerçants des zones rurales, il faut une solution abordable.

Jako Fritz, conseiller principal en matière de sécurité chez UL, a déclaré : « SoftPOS est une approche entièrement nouvelle des paiements numériques qui réduit la barrière d’entrée pour les commerçants afin d’accepter les transactions par carte sans contact. L’informatique cloud, ainsi que le protocole Europay, MasterCard et Visa, permettent de passer du traditionnel point de vente physiquement sécurisé au traitement des transactions par logiciel COTS. Ces solutions aideront les propriétaires de micro-entreprises et de petites entreprises ainsi que les commerçants du monde entier à répondre aux exigences d’une société de plus en plus dépourvue de numéraire, de manière plus sûre et avec un investissement minimal. »

Expliquant comment Tap2Pay répond à un besoin non satisfait du marché, Brian Richardson, PDG et cofondateur de WIZZIT Digital, a déclaré : « Depuis près de deux décennies, nous travaillons avec des banques et des institutions financières sur les marchés émergents, y compris de nombreux pays d’frique. Notre expérience nous a appris deux choses. Tout d’abord, les consommateurs et les banques veulent la protection d’un code PIN lorsqu’ils effectuent des transactions sans contact. Dans un contexte de cyberfraude croissante, le code PIN offre un niveau de sécurité universellement accepté et auquel les gens font confiance. Deuxièmement, les solutions traditionnelles de paiement sans espèces sont trop coûteuses pour les micro et petits commerçants.

« Pour les petits commerçants, l’investissement initial dans les terminaux et les coûts de maintenance permanents sont tout simplement trop élevés. Tap2Pay SoftPos with PIN supprime cette barrière, permettant aux commerçants de toute taille d’accepter les paiements sans espèces. Cela leur permettra en fin de compte d’attirer davantage de clients, y compris ceux qui ne veulent pas payer en liquide des biens et des services, pour une fraction du coût », a déclaré M. Richardson.

À propos d’UL
UL est le leader mondial des sciences de la sécurité. Nous fournissons des services de test, d’inspection et de certification (TIC), de formation et de conseil, des solutions de gestion des risques et des informations commerciales essentielles pour aider nos clients, basés dans plus de 100 pays, à atteindre leurs objectifs de sécurité et de durabilité. Notre connaissance approfondie des produits et notre intelligence des chaînes d’approvisionnement font de nous le partenaire de choix des clients confrontés à des défis complexes. Découvrez-en davantage sur UL.com.

Pour en savoir plus sur le développement des normes et les autres activités à but non lucratif, visitez le site UL.org.

Contacts avec la presse :
Steven Brewster
UL
ULNews@UL.com
+1.847.664.8425

Christina Bostock
IHC
christina@ih-c.com
971.55.887.3054

Photo – https://mma.prnewswire.com/media/1578854/UL_Wizzit.jpg
Logo – https://mma.prnewswire.com/media/325015/ul_enterprise_logo.jpg

July 30, 2021

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

Takeda Will Focus its Efforts on Dengue, Zika and Pandemic Vaccines

Dubai, United Arab Emirates, July 30, 2021 (GLOBE NEWSWIRE) — Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialize Takeda’s norovirus vaccine candidate. Takeda has granted a license to HilleVax for the exclusive development and commercialization rights to its norovirus vaccine candidate, HIL-214 (formerly TAK-214), worldwide outside of Japan. Takeda will retain commercialization rights in Japan and HilleVax will integrate certain Japan development activities into its global development. Takeda remains committed to vaccines and this collaboration allows Takeda to focus primarily on dengue, COVID-19, pandemic influenza and Zika.

HIL-214, which is a virus-like particle (VLP) based vaccine candidate, completed a randomized, placebo-controlled Phase 2b field efficacy study in 4,712 adult subjects in which HIL-214 was well-tolerated and demonstrated clinical proof of concept in preventing moderate-to-severe cases of acute gastroenteritis from norovirus infection.¹ To date, the candidate has been studied in nine human clinical trials with safety data from over 4,500 subjects and immunogenicity data from over 2,000 subjects.

Ursula Belinda Myles, General Manager of Takeda’s Access Market Cluster (covering much of Africa) commented: “Africa’s underlying burden of endemic diseases is one of the largest in the world, and infectious diseases play a larger portion of these diseases across the continent. Like many other nations, COVID-19 has emphasized Africa’s greatest challenges around healthcare and highlighted the need for continued greater investment in healthcare systems. These investments are critical to secure economic development as Africa implements flagship projects around the 2030 Africa Health Strategy.”

Ursula added: “The announcement of our partnership with Frazier Healthcare Partners will allow Takeda to focus efforts and resources on vaccines for diseases prevalent across Africa and provide support in alleviating the growing burden that infectious diseases have on public health systems.”

Norovirus is a common intestinal infection marked by diarrhea, vomiting, abdominal cramps, nausea and sometimes fever that may lead to clinically significant dehydration.² Norovirus is recognized as the leading cause of acute gastroenteritis across the age spectrum.³ It is estimated that norovirus causes nearly 700 million cases of illness and more than 200,000 deaths worldwide per year with significant additional economic and social burden.³ No vaccines are currently approved for norovirus infection, and HIL-214 continues to be the most advanced norovirus vaccine candidate in human clinical trials.

“Takeda and Frazier have a history of successfully partnering together, and we are confident in HilleVax’s capabilities to progress HIL-214, the most advanced norovirus vaccine candidate in development with the potential to address the huge global burden of norovirus-associated acute gastroenteritis,” said Rajeev Venkayya, M.D., President of the Global Vaccine Business Unit, Takeda. “This will allow Takeda to focus its efforts and resources on our dengue vaccine, which we have begun filing for licensure around the world, our pandemic programs, and our partnership with the US Government to develop a Zika vaccine

Takeda’s Commitment to Vaccines

Vaccines prevent 2 to 3 million deaths each year and have transformed global public health. For more than 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, COVID-19, pandemic influenza and Zika. Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development and manufacturing to advance a pipeline of vaccines to address some of the world’s most pressing public health needs. For more information, visit www.TakedaVaccines.com.

About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com.

About Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With nearly $4.8 billion total capital raised, Frazier has invested in over 200 companies, with investment types ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, WA and Menlo Park, CA, and invests broadly across the US, Canada, and Europe. For more information about Frazier Healthcare Partners, visit the company’s website at http://www.frazierhealthcare.com.

About HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates. Its initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. For more information about HilleVax, visit the company’s website at http://www.HilleVax.com.

Takeda Pharmaceutical Company Limited Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/reports/sec-filings/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

CONTACTS:

Takeda Media Contacts:
Japanese Media Ryoko Matsumoto ryoko.matsumoto@takeda.com +81 (0) 3-3278-3414	edia Outside Japan Amy Atwood amy.atwood@takeda.com +1-774-571-3316
For HilleVax, Inc.:	For Frazier Healthcare Partners:
David Socks info@hillevax.com +1-650-325-5156	Liz Park liz.park@frazierhealthcare.com +1-650-319-1831

References

¹Sherwood J, et al. Vaccine 2020; 38(41):6442-6449

²https://ww.cdc.gov/norovirus/index.html [accessed 2021 April 27].

³Hall AJ, et al. Expert Rev Vaccines 2016;15(8):949-951

Mohammed Al Nasseri
Takeda Pharmaceuticals
+971507694646
Mohammed.alnasseri@fleishman.com

July 30, 2021

L’industrie chinoise des circuits intégrés accélère la production avancée de puces (expert)

BEIJING, 30 juillet 2021 /PRNewswire/ — Article publié sur China.org.cn.

L’industrie chinoise des circuits intégrés est en train de passer d’un développement à grande vitesse à un développement de grande qualité, alors que les procédés nationaux et plus avancés de fabrication de puces font des percées dans l’ensemble de la chaîne industrielle, a déclaré un expert.

Dans un article publié au début du mois sur Guancha.cn, un agrégateur d’informations et de commentaires en ligne basé à Shanghai, le Dr Bao Yungang, vice-directeur de l’Institut des technologies informatiques (ICT) de l’Académie chinoise des sciences (CAS), a noté que les procédés chinois de fabrication de puces en 14 nm et 28 nm gagnaient du terrain et étaient utilisés pour de nombreuses applications dans divers domaines.

China's homegrown AI chips are on display at the 2021 World Artificial Intelligence Conference in Shanghai, July 7, 2021. [Photo/VCG]

Le processus de fabrication des puces en 14 nm du pays a surmonté de nombreuses difficultés technologiques grâce à des améliorations significatives des techniques de fabrication, des technologies de conditionnement et des matériaux d’équipement clés, a déclaré M. Bao.

Il a ajouté que le nœud de 14 nm est le procédé de fabrication de puces le plus largement utilisé dans des domaines tels que l’électronique grand public haut de gamme, l’informatique à haut débit, l’intelligence artificielle et l’automobile.

Selon les statistiques, le marché mondial des semi-conducteurs a réalisé environ 200 milliards de dollars de ventes au premier semestre 2019. Le procédé de fabrication de puces en 14 nm a représenté 65% de ces ventes.

M. Bao a déclaré que la Chine était désormais en mesure de produire en masse des puces en 28 nm, alors que le pays a réalisé d’importants progrès dans le développement de certains équipements et matériels essentiels.

28 nm est la ligne de démarcation entre la fabrication de circuits intégrés (CI) de basse à moyenne gamme et de milieu à haut de gamme, a-t-il expliqué.

Outre les puces pour les processeurs, les cartes graphiques et l’intelligence artificielle (IA), d’autres produits industriels courants tels que les télévisions, les climatiseurs, les automobiles, les trains à grande vitesse, les satellites, les robots industriels, les ascenseurs et les drones sont les applications les plus courantes pour le processus technologique de 28 nm, a ajouté M. Bao.

« La Chine doit de toute urgence se diriger vers la production de puces haut de gamme, car être capable de produire des puces en 28 nm signifie qu’elle peut répondre à la majeure partie de la demande de puces sans compter sur d’autres pays », a-t-il souligné.

En 2019, la capacité de production des circuits intégrés pour les procédés de pointe (<10 nm) ne représentait que 4,4% de la capacité installée dans l’ensemble du secteur, tandis que les procédés supérieurs à 28 nm représentaient 52% de la part globale, selon le rapport « Global Wafer Capacity 2020-2024 » publié par IC Insights.

Alors que les procédés de fabrication de puces en 14 nm et 28 nm peuvent répondre à une grande partie de la demande intérieure, la Chine s’efforce de promouvoir des procédés de pointe afin de s’affranchir progressivement de sa dépendance vis-à-vis de l’étranger.

Wen Xiaojun, directeur de l’Institut de l’information électronique au Centre chinois pour le développement de l’industrie de l’information (CCID), a déclaré au portail d’information chinois huanqiu.com, que le procédé national de fabrication de puces en 14 nm devrait être produit en masse d’ici l’année prochaine.

En tant que plus grand marché mondial de semi-conducteurs, la Chine a investi considérablement dans l’acquisition de semi-conducteurs et dans le recrutement de talents afin de soutenir l’industrie de la fabrication de puces et la rendre identique à celle des meilleures fonderies du monde.

Un rapport de Goldman Sachs publié l’année dernière prévoit que la Chine devrait être en mesure de produire des puces de 7 nm d’ici 2023.

Étant donné la dynamique du secteur de la production de puces, les opérateurs de communication nationaux, les fournisseurs d’équipements et les fournisseurs de services de communication doivent étudier de nouveaux modes de service tout en innovant l’architecture des appareils pour gagner la confiance des clients et stimuler les progrès technologiques, a noté M. Bao.

Selon lui, la clé pour arriver à de nouvelles avancées réside dans une meilleure intégration au sein du système mondial d’innovation et de collaboration, car « l’industrie des circuits intégrés est vraiment une industrie mondiale et aucun pays ne doit être isolé de la chaîne industrielle ».

Photo – https://mma.prnewswire.com/media/1583059/China_org_cn.jpg